Clinical Outcomes

Nozin® NOVASM programs utilize a proven approach to help reduce the risk of infections, to improve care and to lower costs. These programs include the use of Nozin® Nasal Sanitizer® antiseptic and are supported by the independent clinical studies cited below. Also, watch clinicians report in their own words on improved outcomes at APIC Symposium.


Health Professionals:
Request a comprehensive analysis of your MRSA & MSSA colonization risk mitigation protocols today.

© 2004-2021 Global Life Technologies Corp. All rights reserved. Nozin® Nasal Sanitizer® antiseptic is an OTC topical antiseptic drug and no claim is made that it has an effect on any specific disease. | Patent Nos.